Cargando…
High-dose Intensity-modulated proton therapy versus Standard-dose Intensity-modulated RadIation therapy for esophageal squamous cell carcinoma (HI-SIRI): study protocol for a randomized controlled clinical trial
BACKGROUND: Chemoradiotherapy is the standard of care for esophageal cancer as a neoadjuvant treatment before surgery, or as a definitive treatment for unresectable disease. Intensity-modulated radiotherapy (IMRT) has been considered the standard radiation technique. However, patients suffer from tr...
Autores principales: | Lertbutsayanukul, Chawalit, Kitpanit, Sarin, Kannarunimit, Danita, Chakkabat, Chakkapong, Oonsiri, Sornjarod, Thephamongkhol, Kullathorn, Puataweepong, Putipun, Katanyoo, Kanyarat, Sukhaboon, Jirasak, Tovanabut, Chokaew, Chongsathientham, Sirikanya, Treeratsapanich, Pornravee, Soonthornrak, Jirarat, Prayongrat, Anussara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587557/ https://www.ncbi.nlm.nih.gov/pubmed/36273186 http://dx.doi.org/10.1186/s13063-022-06822-8 |
Ejemplares similares
-
Comparison of intensity modulated proton therapy beam configurations for treating thoracic esophageal cancer
por: Oonsiri, Sornjarod, et al.
Publicado: (2022) -
Improved prediction of radiation-induced hypothyroidism in nasopharyngeal carcinoma using pre-treatment CT radiomics
por: Ritlumlert, Napat, et al.
Publicado: (2023) -
Tumor Prognostic Prediction of Nasopharyngeal Carcinoma Using CT-Based Radiomics in Non-Chinese Patients
por: Intarak, Sararas, et al.
Publicado: (2022) -
Prognostic Value of Plasma EBV DNA for Nasopharyngeal Cancer Patients during Treatment with Intensity-modulated Radiation Therapy and Concurrent Chemotherapy
por: Lertbutsayanukul, Chawalit, et al.
Publicado: (2018) -
Validation of previously reported predictors for radiation-induced hypothyroidism in nasopharyngeal cancer patients treated with intensity-modulated radiation therapy, a post hoc analysis from a Phase III randomized trial
por: Lertbutsayanukul, Chawalit, et al.
Publicado: (2018)